Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.d7202 (Published 3 January 2012)
Cite this as: BMJ 2012;344:d7202

Related articles

Research: Non-publication of large randomized clinical trials: cross sectional analysis

Research Methods & Reporting: SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

News: FDA given new powers over data reporting to national clinical trials registry

Editorial: Open science and reproducible research

Editorial: Missing clinical trial data

Analysis: Opening up data at the European Medicines Agency

Research: Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

Research Methods & Reporting: The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

Research Methods & Reporting: Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers

Paper: Optimal search strategies for retrieving systematic reviews from Medline: analytical survey

PAPERS: Optimal search strategies for retrieving systematic reviews from Medline: analytical survey

Paper: Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

See more

Clinical Review: Obsessive-compulsive disorder

Editorial: Does agomelatine have a place in the treatment of depression?

Letter: Huffman and colleagues’ response to Abramson and colleagues’ article on statins in low risk people

Letter: Authors’ reply to Huffman and colleagues

This article has been cited by other articles:

THIS WEEK'S POLL